Literature DB >> 14636650

The emerging role of the myeloid Elf-1 like transcription factor in hematopoiesis.

H Daniel Lacorazza1, Stephen D Nimer.   

Abstract

MEF (myeloid Elf-1 like factor) is a member of the ETS family of transcription factors (TF) with transcriptional activating properties. ETS proteins have been implicated in widely divergent physiological and pathological processes (such as development and oncogenesis). MEF is expressed in non-hematopoietic and hematopoietic (lymphoid and myeloid) tissues, and after generating MEF-deficient mice by homologous recombination, we have studied its role in lymphopoiesis (Immunity 17 (2002), 437). MEF plays a critical role in NK and NK-T cell development and the constitutive expression of perforin by NK cells. MEF interacts with other TFs such as AML1 (Runx1) and with the cyclin A/cdk2 kinase complex. In this review, we discuss the biology of MEF in the context of the other members of this family of transcriptional regulators.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14636650     DOI: 10.1016/s1079-9796(03)00162-1

Source DB:  PubMed          Journal:  Blood Cells Mol Dis        ISSN: 1079-9796            Impact factor:   3.039


  12 in total

1.  The mef/elf4 transcription factor fine tunes the DNA damage response.

Authors:  Goro Sashida; Narae Bae; Silvana Di Giandomenico; Takashi Asai; Nadia Gurvich; Elena Bazzoli; Yan Liu; Gang Huang; Xinyang Zhao; Silvia Menendez; Stephen D Nimer
Journal:  Cancer Res       Date:  2011-05-26       Impact factor: 12.701

Review 2.  Sustained proliferation in cancer: Mechanisms and novel therapeutic targets.

Authors:  Mark A Feitelson; Alla Arzumanyan; Rob J Kulathinal; Stacy W Blain; Randall F Holcombe; Jamal Mahajna; Maria Marino; Maria L Martinez-Chantar; Roman Nawroth; Isidro Sanchez-Garcia; Dipali Sharma; Neeraj K Saxena; Neetu Singh; Panagiotis J Vlachostergios; Shanchun Guo; Kanya Honoki; Hiromasa Fujii; Alexandros G Georgakilas; Alan Bilsland; Amedeo Amedei; Elena Niccolai; Amr Amin; S Salman Ashraf; Chandra S Boosani; Gunjan Guha; Maria Rosa Ciriolo; Katia Aquilano; Sophie Chen; Sulma I Mohammed; Asfar S Azmi; Dipita Bhakta; Dorota Halicka; W Nicol Keith; Somaira Nowsheen
Journal:  Semin Cancer Biol       Date:  2015-04-17       Impact factor: 15.707

Review 3.  The oncogenic role of the ETS transcription factors MEF and ERG.

Authors:  Goro Sashida; Elena Bazzoli; Silvia Menendez; Yan Liu; Stephen D Nimer
Journal:  Cell Cycle       Date:  2010-09-13       Impact factor: 4.534

4.  The transcription factor E74-like factor controls quiescence of endothelial cells and their resistance to myeloablative treatments in bone marrow.

Authors:  Mariela Sivina; Takeshi Yamada; Chun Shik Park; Monica Puppi; Suleyman Coskun; Karen Hirschi; H Daniel Lacorazza
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-02-24       Impact factor: 8.311

5.  The transcription factor E74-like factor 4 suppresses differentiation of proliferating CD4+ T cells to the Th17 lineage.

Authors:  Ping-Hsien Lee; Monica Puppi; Kimberly S Schluns; Li-Yuan Yu-Lee; Chen Dong; H Daniel Lacorazza
Journal:  J Immunol       Date:  2013-11-20       Impact factor: 5.422

Review 6.  Inactivation of X-linked tumor suppressor genes in human cancer.

Authors:  Runhua Liu; Mandy Kain; Lizhong Wang
Journal:  Future Oncol       Date:  2012-04       Impact factor: 3.404

7.  The synergistic regulatory effect of Runx2 and MEF transcription factors on osteoblast differentiation markers.

Authors:  Jae-Mok Lee; Towia A Libermann; Je-Yoel Cho
Journal:  J Periodontal Implant Sci       Date:  2010-02-28       Impact factor: 2.614

8.  PP2A dephosphorylates Elf-1 and determines the expression of CD3zeta and FcRgamma in human systemic lupus erythematosus T cells.

Authors:  Yuang-Taung Juang; Ying Wang; Guisen Jiang; Hai-Bin Peng; Sukran Ergin; Michelle Finnell; Abigail Magilavy; Vasileios C Kyttaris; George C Tsokos
Journal:  J Immunol       Date:  2008-09-01       Impact factor: 5.422

9.  Transcription factor ELF4 controls the proliferation and homing of CD8+ T cells via the Krüppel-like factors KLF4 and KLF2.

Authors:  Takeshi Yamada; Chun Shik Park; Maksim Mamonkin; H Daniel Lacorazza
Journal:  Nat Immunol       Date:  2009-05-03       Impact factor: 25.606

10.  Connections between ETV6-modulated genes: identification of shared features.

Authors:  Gino Boily; Patrick Beaulieu; Jasmine Healy; Daniel Sinnett
Journal:  Cancer Inform       Date:  2008-04-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.